Skip to main content

Find Clinical Trials

Home
Conditions
Essential Hypertension

Clinical trial condition

Essential Hypertension

Explore clinical trials studying Essential Hypertension. Study availability and eligibility vary by location and protocol.

217 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Essential Hypertension trial results

Completed

Hybrid Blood Pressure Monitor Validation

NCT01120990

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Hypertension Center, Third Department of Medicine, University of Athens, Greece Athens, Greece

View Trial Details

Completed

Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients

NCT01042392

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Novartis Investigative Site Aire Sur Adour, France

Novartis Investigative Site Amboise, France

Novartis Investigative Site Angers, France

Novartis Investigative Site Anzin, France

View all 98 locations

View Trial Details

Completed

Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension

NCT00846365

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Birmingham, Alabama, United States

Haleyville, Alabama, United States

Hueytown, Alabama, United States

Jasper, Alabama, United States

View all 80 locations

View Trial Details

Completed

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension

NCT00818883

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Birmingham, Alabama, United States

Gulf Shores, Alabama, United States

Scottsboro, Alabama, United States

Gilbert, Arizona, United States

View all 53 locations

View Trial Details

Completed

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

NCT01033071

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Gulf Shores, Alabama, United States

Litchfield Park, Arizona, United States

Mesa, Arizona, United States

Scottsdale, Arizona, United States

View all 94 locations

View Trial Details

Completed

A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy

NCT01258673

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Seoul National University Hospital, Bundang Sungnam, South Korea

View Trial Details

Completed

A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers

NCT01146938

Conditions: Cardiovascular Diseases, Essential Hypertension, Hepatic Impairment, +2 more
Locations: Severance Hospital Seoul, South Korea

View Trial Details

Completed

Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension.

NCT00654875

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Investigative Site Zanesville, Ohio, United States

Investigative Site Frankfurt, Germany

Investigative Site Valencia, Spain

View Trial Details

Completed

Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur Study

NCT00408512

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Ambulatorio Ipertensione e Unità Coronarica Federico II University Naples, Italy

View Trial Details

Completed

Efficacy of Rostafuroxin in the Treatment of Essential Hypertension

NCT00415038

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Catholic University of Leuven - Laboratory of Hypertension, Dept. of Molecular and Cardiov. Research - Campus Gasthuisberg Leuven, Belgium

View Trial Details